Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Income Statement
Earnings Waterfall
Amphastar Pharmaceuticals Inc
Revenue
|
644.4m
USD
|
Cost of Revenue
|
-290.6m
USD
|
Gross Profit
|
353.8m
USD
|
Operating Expenses
|
-154.1m
USD
|
Operating Income
|
199.7m
USD
|
Other Expenses
|
-62.1m
USD
|
Net Income
|
137.5m
USD
|
Income Statement
Amphastar Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
230
N/A
|
223
-3%
|
209
-6%
|
210
+0%
|
211
+0%
|
222
+5%
|
226
+2%
|
231
+2%
|
252
+9%
|
254
+1%
|
268
+6%
|
269
+0%
|
255
-5%
|
252
-1%
|
250
-1%
|
243
-3%
|
240
-1%
|
242
+1%
|
248
+2%
|
265
+7%
|
295
+11%
|
316
+7%
|
324
+3%
|
329
+1%
|
322
-2%
|
327
+1%
|
334
+2%
|
337
+1%
|
350
+4%
|
368
+5%
|
384
+4%
|
413
+8%
|
438
+6%
|
455
+4%
|
477
+5%
|
485
+2%
|
499
+3%
|
519
+4%
|
541
+4%
|
601
+11%
|
644
+7%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(143)
|
(143)
|
(142)
|
(151)
|
(159)
|
(169)
|
(176)
|
(174)
|
(174)
|
(165)
|
(161)
|
(151)
|
(151)
|
(150)
|
(153)
|
(153)
|
(150)
|
(157)
|
(164)
|
(173)
|
(188)
|
(195)
|
(197)
|
(196)
|
(190)
|
(190)
|
(195)
|
(197)
|
(207)
|
(217)
|
(218)
|
(233)
|
(238)
|
(245)
|
(250)
|
(251)
|
(250)
|
(252)
|
(265)
|
(275)
|
(291)
|
|
Gross Profit |
87
N/A
|
80
-8%
|
67
-16%
|
59
-13%
|
51
-13%
|
52
+2%
|
50
-3%
|
56
+12%
|
77
+38%
|
89
+15%
|
107
+21%
|
117
+9%
|
104
-11%
|
102
-2%
|
97
-5%
|
90
-7%
|
91
+1%
|
85
-6%
|
84
-1%
|
93
+10%
|
107
+15%
|
121
+13%
|
127
+5%
|
133
+5%
|
132
-1%
|
138
+5%
|
139
+1%
|
140
+1%
|
143
+2%
|
151
+6%
|
166
+9%
|
180
+9%
|
200
+11%
|
211
+5%
|
227
+8%
|
234
+3%
|
249
+6%
|
267
+7%
|
276
+3%
|
326
+18%
|
354
+9%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(69)
|
(66)
|
(67)
|
(66)
|
(69)
|
(75)
|
(83)
|
(84)
|
(84)
|
(84)
|
(82)
|
(82)
|
(89)
|
(92)
|
(96)
|
(97)
|
(94)
|
(97)
|
(102)
|
(105)
|
(116)
|
(123)
|
(125)
|
(131)
|
(132)
|
(127)
|
(132)
|
(132)
|
(132)
|
(138)
|
(138)
|
(132)
|
(130)
|
(129)
|
(131)
|
(140)
|
(141)
|
(148)
|
(145)
|
(154)
|
(154)
|
|
Selling, General & Administrative |
(36)
|
(36)
|
(38)
|
(38)
|
(40)
|
(46)
|
(49)
|
(48)
|
(47)
|
(45)
|
(43)
|
(45)
|
(47)
|
(48)
|
(51)
|
(52)
|
(51)
|
(51)
|
(51)
|
(53)
|
(58)
|
(65)
|
(67)
|
(66)
|
(63)
|
(58)
|
(62)
|
(63)
|
(65)
|
(71)
|
(70)
|
(70)
|
(69)
|
(67)
|
(64)
|
(65)
|
(67)
|
(69)
|
(73)
|
(75)
|
(80)
|
|
Research & Development |
(33)
|
(30)
|
(29)
|
(28)
|
(28)
|
(29)
|
(34)
|
(36)
|
(37)
|
(38)
|
(36)
|
(34)
|
(42)
|
(41)
|
(41)
|
(42)
|
(39)
|
(41)
|
(45)
|
(46)
|
(52)
|
(52)
|
(52)
|
(58)
|
(60)
|
(61)
|
(61)
|
(59)
|
(57)
|
(56)
|
(58)
|
(51)
|
(50)
|
(52)
|
(57)
|
(65)
|
(65)
|
(69)
|
(63)
|
(61)
|
(64)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(4)
|
0
|
(4)
|
(4)
|
(3)
|
(5)
|
(6)
|
(6)
|
(6)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
|
Operating Income |
18
N/A
|
13
-24%
|
0
-97%
|
(8)
N/A
|
(18)
-132%
|
(23)
-31%
|
(32)
-40%
|
(28)
+13%
|
(7)
+76%
|
5
N/A
|
26
+420%
|
35
+37%
|
15
-56%
|
10
-36%
|
2
-85%
|
(7)
N/A
|
(4)
+46%
|
(12)
-218%
|
(17)
-40%
|
(12)
+32%
|
(9)
+27%
|
(2)
+77%
|
2
N/A
|
2
-11%
|
0
N/A
|
11
N/A
|
7
-36%
|
8
+16%
|
11
+39%
|
14
+25%
|
27
+98%
|
49
+78%
|
70
+44%
|
81
+16%
|
96
+17%
|
94
-2%
|
108
+14%
|
119
+11%
|
131
+10%
|
172
+31%
|
200
+16%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
(12)
|
(19)
|
|
Non-Reccuring Items |
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(3)
|
14
|
14
|
13
|
11
|
(5)
|
(5)
|
(5)
|
(8)
|
0
|
(6)
|
|
Total Other Income |
1
|
0
|
(0)
|
(1)
|
0
|
2
|
3
|
2
|
(3)
|
(4)
|
(5)
|
(4)
|
0
|
0
|
2
|
2
|
3
|
4
|
1
|
0
|
(2)
|
(3)
|
58
|
57
|
59
|
58
|
(1)
|
4
|
(7)
|
(6)
|
(5)
|
(12)
|
1
|
15
|
11
|
14
|
15
|
7
|
7
|
10
|
(4)
|
|
Pre-Tax Income |
17
N/A
|
13
-27%
|
(1)
N/A
|
(10)
-638%
|
(18)
-89%
|
(22)
-21%
|
(30)
-38%
|
(27)
+12%
|
(10)
+61%
|
(0)
+96%
|
20
N/A
|
30
+53%
|
15
-51%
|
12
-15%
|
6
-55%
|
(3)
N/A
|
1
N/A
|
(9)
N/A
|
(16)
-79%
|
(12)
+29%
|
(10)
+15%
|
(5)
+54%
|
61
N/A
|
60
-2%
|
60
+1%
|
70
+16%
|
7
-90%
|
13
+77%
|
5
-63%
|
4
-13%
|
20
+393%
|
50
+155%
|
84
+68%
|
108
+28%
|
117
+8%
|
102
-13%
|
116
+14%
|
121
+4%
|
130
+8%
|
171
+31%
|
171
+0%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(5)
|
(5)
|
0
|
3
|
7
|
12
|
15
|
14
|
8
|
1
|
(6)
|
(9)
|
(5)
|
(4)
|
(2)
|
2
|
2
|
5
|
7
|
4
|
3
|
3
|
(13)
|
(12)
|
(14)
|
(18)
|
(3)
|
(5)
|
(4)
|
(2)
|
(8)
|
(13)
|
(21)
|
(24)
|
(24)
|
(24)
|
(24)
|
(26)
|
(27)
|
(35)
|
(32)
|
|
Income from Continuing Operations |
12
|
8
|
(1)
|
(6)
|
(11)
|
(10)
|
(15)
|
(13)
|
(3)
|
0
|
14
|
21
|
10
|
8
|
3
|
(1)
|
4
|
(4)
|
(9)
|
(8)
|
(7)
|
(2)
|
48
|
47
|
47
|
52
|
4
|
8
|
1
|
2
|
12
|
38
|
64
|
85
|
94
|
79
|
93
|
94
|
103
|
137
|
140
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
5
|
4
|
2
|
(0)
|
0
|
(1)
|
0
|
1
|
(1)
|
(2)
|
(1)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
Net Income (Common) |
12
N/A
|
8
-34%
|
(1)
N/A
|
(6)
-433%
|
(11)
-67%
|
(10)
+8%
|
(15)
-55%
|
(13)
+16%
|
(3)
+78%
|
0
N/A
|
14
+3 375%
|
21
+50%
|
10
-53%
|
8
-16%
|
3
-61%
|
(1)
N/A
|
4
N/A
|
(4)
N/A
|
(9)
-112%
|
(7)
+25%
|
(6)
+16%
|
2
N/A
|
53
+2 204%
|
52
-2%
|
49
-6%
|
52
+6%
|
4
-92%
|
7
+65%
|
1
-79%
|
2
+71%
|
10
+333%
|
36
+246%
|
62
+73%
|
81
+31%
|
91
+12%
|
77
-15%
|
91
+18%
|
93
+2%
|
102
+9%
|
135
+33%
|
138
+2%
|
|
EPS (Diluted) |
0.27
N/A
|
0.18
-33%
|
-0.03
N/A
|
-0.15
-400%
|
-0.26
-73%
|
-0.22
+15%
|
-0.34
-55%
|
-0.29
+15%
|
-0.06
+79%
|
0
N/A
|
0.3
N/A
|
0.45
+50%
|
0.21
-53%
|
0.18
-14%
|
0.07
-61%
|
-0.01
N/A
|
0.08
N/A
|
-0.09
N/A
|
-0.19
-111%
|
-0.14
+26%
|
-0.12
+14%
|
0.05
N/A
|
1.07
+2 040%
|
1.05
-2%
|
0.98
-7%
|
1.07
+9%
|
0.09
-92%
|
0.14
+56%
|
0.03
-79%
|
0.05
+67%
|
0.21
+320%
|
0.72
+243%
|
1.25
+74%
|
1.56
+25%
|
1.7
+9%
|
1.46
-14%
|
1.74
+19%
|
1.79
+3%
|
1.91
+7%
|
2.5
+31%
|
2.6
+4%
|